Nova Eye Medical FY2023 Annual Results – ASX:EYE

Nova Eye Medical reported record global sales of US$11.3m in glaucoma surgical devices for the year ended 30 June 2023, with gross margins improving to 73%. The company maintained A$7.4m in cash and demonstrated strong growth momentum in the USA market, with Q3 sales up 32% year-on-year driven by the iTrack Advance product.